Chernigovskaya M, Lê Quý K, Stensland M, Singh S, Nelson R, Yilmaz M, Kalogeropoulos K, Sinitcyn P, Patel A, Castellana N, Bonissone S, Foss S, Andersen JT, Sandve GK, Jenkins TP, Noble WS, Nyman TA, Snapkow I, Greiff V(2025) Systematic benchmarking of mass spectrometry-based antibody sequencing reveals methodological biases Cell Syst, 101449(in press) DOI 10.1016/j.cels.2025.101449, PubMed 41232534
Abrantes R, Forcados C, Warren DJ, Santos-Ferreira L, Fleten KG, Senra E, Costa AF, Krpina K, Henrique R, Liberg AM, Rawat P, Gelebart P, McCormack E, Bjørge L, Davidson B, Greiff V, Costea DE, Pinto F, Flatmark K, Gomes C, Inderberg EM, Reis CA, Wälchli S(2025) Pan-carcinoma sialyl-Tn-targeting expands CAR therapy to solid tumors Cell Rep Med, 6(9), 102350 DOI 10.1016/j.xcrm.2025.102350, PubMed 40925376
Bielska W, Jaszczyszyn I, Dudzic P, Janusz B, Chomicz D, Wrobel S, Greiff V, Feehan R, Adolf-Bryfogle J, Krawczyk K(2025) Applying computational protein design to therapeutic antibody discovery - current state and perspectives Front Immunol, 16, 1571371 DOI 10.3389/fimmu.2025.1571371, PubMed 40475769
